F.H. INVESTMENTS, Inc. (dba Asteria Health) recalls
25 recalls.
- Testosterone 100mg Anastrozole 4mg recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - Testosterone 87.5mg recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - Testosterone 200mg recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - Testosterone 100mg recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - Testosterone 75mg recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - Testosterone 100mg recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - Testosterone recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - Testosterone recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - Testosterone recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - Testosterone recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - Testosterone recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - Testosterone recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - Testosterone recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - Testosterone recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - Testosterone recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - Testosterone recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - ESTRADIOL recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - ESTRADIOL recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - ESTRADIOL recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - ESTRADIOL recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - ESTRADIOL recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - ESTRADIOL recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - ESTRADIOL recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - ESTRADIOL recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter - ESTRADIOL recall (F.H. INVESTMENTS, Inc. (dba Asteria Health))
DrugClass IIReported February 18, 2026 · Presence of Foreign substance - potential presence of metal particulate matter